During Friday’s Afternoon trade, Shares of Clorox Co (NYSE:CLX), lost -1.48% to $109.69.
The Clorox Company (CLX) will be recognized at the 2015 White House Conference on Aging as one of the companies with a “best in class” retirement plan for its employees. The conference, held once every 10 years, will feature an open dialogue on retirement and aging issues. Over 200 stakeholders will be in attendance, counting President Barack Obama, cabinet members and other CEOs, with thousands more participating through webcasts.
The Clorox Company manufactures and markets consumer and professional products worldwide. The company operates in four segments: Cleaning, Household, Lifestyle, and International. It offers laundry products, counting bleach products under the Clorox brand, and stain fighter and color booster products under the Clorox 2 brand; home-care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived home care products under the Green Works brand; and cleaning and disinfecting products under the Clorox, Dispatch, Aplicare, HealthLink, and Clorox Healthcare brands.
Shares of Oncothyreon Inc (USA) (NASDAQ:ONTY), declined -0.60% to $3.33, during its Afternoon trading session.
Oncothyreon Inc. (ONTY) reported financial results for the second quarter ended June 30, 2015.
Net loss for the three months ended June 30, 2015 was $10.9 million, or $0.11 per basic and diluted share, compared with a net loss of $6.0 million, or $0.09 per basic and diluted share, for the comparable period in 2014. The $4.9 million increase in net loss was primarily attributable to the difference in the change in the fair value of warrant liability of $4.3 million. The increase in net loss was also due to increases in research and development expenses of $0.3 million and increases in general and administrative expenses of $0.2 million.
Net loss for the six months ended June 30, 2015 was $18.8 million, or $0.19 per basic and diluted share, compared with a net loss of $15.6 million, or $0.22 per basic and diluted share, for the comparable period in 2014. The $3.2 million increase in net loss was attributable to the difference in the change in the fair value of warrant liability of $1.7 million, increases in research and development expenses of $1.3 million and increases in general and administrative expenses of $0.2 million.
Oncothyreon Inc., a clinical-stage biopharmaceutical company, engages in the research and development of therapeutic products for the treatment of cancer. Its clinical-stage product candidates comprise ONT-380, an orally active and selective small-molecule HER2 inhibitor, which is in two Phase 1b trials, one in combination with Kadcyla and another in combination with Xeloda and/or Herceptin; and ONT-10, a therapeutic vaccine in Phase 1 trial targeting the Mucin 1 peptide antigen (MUC1) for use in various cancer indications, counting breast, thyroid, colon, stomach, pancreas, ovarian, and prostate, in addition to certain types of lung cancer.
Sun Life Financial Inc(NYSE:SLF), during its Friday’s Afternoon trading session decreased -1.43% to $31.02.
Sun Life Financial Inc (SLF) declared that 6,007,314 of its 11,200,000 Class A Non-cumulative Rate Reset Preferred Shares Series 8R (the “Series 8R Shares”) have been elected for conversion on June 30, 2015, on a one-for-one basis, into Class A Non-cumulative Floating Rate Preferred Shares Series 9QR (the “Series 9QR Shares”). Consequently, on June 30, 2015, Sun Life Financial will have 5,192,686 Series 8R Shares and 6,007,314 Series 9QR Shares issued and outstanding. The Series 8R Shares and Series 9QR Shares will be listed on the Toronto Stock Exchange under the symbols SLF.PR.G and SLF.PR.J, respectively.
Subject to regulatory approval, Sun Life Financial may redeem the Series 8R Shares and the Series 9QR Shares in whole or in part on June 30, 2020 and on the 30th of June every five years thereafter.
Sun Life Financial Inc., a financial services organization, provides protection and wealth products and services to individuals and corporate customers worldwide. It operates through Sun Life Financial Canada, Sun Life Financial United States, MFS Investment Administration, and Sun Life Financial Asia segments.
Finally, Northern Tier Energy LP(NYSE:NTI), decreased -1.37%, to $23.83.
TIER REIT, Inc. (TIER), a Dallas-based real estate investment trust, declared that its board of directors has declared a cash distribution of $0.18 per share of common stock for the third quarter of 2015. The distribution will be paid on October 8, 2015 to stockholders of record on September 30, 2015.
Distributions are authorized at the discretion of the company’s board of directors based on its analysis of numerous factors, counting but not limited to the company’s forthcoming cash needs and financial condition, and there is no assurance that distributions will continue or at any particular rate or timing.
TIER REIT, Inc is real estate investment trust. The firm invests in the real estate markets of the United States. It primarily owns and operates high quality office properties located in selective markets throughout the United States. The firm makes investments in commercial office real estate to create its portfolio. The firm was formerly known as Behringer Harvard REIT I Inc. TIER REIT, Inc was formed in June 2002 and is based in Dallas, Texas with additional offices in Atlanta, Georgia; Chicago, Illinois; Louisville; Kentucky.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
